Paydirt
TW
Insider

Todd Franklin Watanabe

See Remarks

Todd Franklin Watanabe (See Remarks) filed 5 Form 4 reports in the past 24 months (0 purchases, 5 sales), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $272K of ARQT (20,880 sh × $13.03, as filed), executed Mar 3 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.0M
shares × price, as filed
Last traded
May 2 2025
Filed May 5 2025

Median ADV $51.3M across their filed names

Open performance
Volume by month
$272K$136K$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2024 · sells $120KDec 2024 · sells $228KFeb 2025 · sells $245KMar 2025 · sells $272KMay 2025 · sells $174K
Buys $0 Sells $1.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 5 filings

Sector per market data · by filing · past 24 months

Most traded names
ARQT Arcutis Biotherapeutics, Inc. ARQT · 0 buys · 5 sells 5 filings
Recent filings
ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $174K
11,448 sh × $15.19
Exec May 2 2025
Filed May 5 2025 · 5:30 PM ET
ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $272K
20,880 sh × $13.03
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET
ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $245K
19,301 sh × $12.70
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET
ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $228K
15,000 sh × $15.17
Exec Dec 20 2024
Filed Dec 23 2024 · 5:30 PM ET
ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $120K
13,871 sh × $8.68
Exec Nov 4 2024
Filed Nov 5 2024 · 5:30 PM ET